Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 4/20 | 0.39 |
| ▸ | DRD2 | P14416 | 5/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | MMP8 | P22894 | 2/20 | 0.38 |
| ▸ | MMP13 | P45452 | 2/20 | 0.38 |
| ▸ | GBA1 | P04062 | 1/20 | 0.38 |
| ▸ | NCF1 | P14598 | 4/20 | 0.37 |
| ▸ | CACNA1F | O60840 | 3/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.36 |
| ▸ | CACNA1D | Q01668 | 3/20 | 0.36 |
| ▸ | CACNA1S | Q13698 | 3/20 | 0.36 |
| ▸ | CACNA1C | Q13936 | 3/20 | 0.36 |
| ▸ | CYBB | P04839 | 1/20 | 0.36 |
| ▸ | NOX5 | Q96PH1 | 1/20 | 0.36 |
| ▸ | DRD4 | P21917 | 2/20 | 0.36 |
| ▸ | DRD3 | P35462 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27269271 | 0.99 | GBA1 (0.39) | DGAT1DRD2MMP2MMP9MMP8 | |
| SCHEMBL17776308 | 0.89 | DGAT1 (0.48) | DGAT1MMP2MMP9MMP8MMP13 | |
| SCHEMBL17776309 | 0.87 | CSNK2A1 (0.41) | DGAT1DRD2MMP2MMP9MMP8 | |
| SCHEMBL24894084 | 0.86 | EPHX2 (0.51) | DRD2GBA1 | |
| SCHEMBL24916753 | 0.85 | EPHX2 (0.53) | DRD2GBA1 | |
| SCHEMBL23194394 | 0.84 | DRD2 (0.39) | DGAT1DRD2MMP2MMP9MMP8 | |
| SCHEMBL18768818 | 0.84 | EPHX2 (0.46) | DRD2 | |
| SCHEMBL18770918 | 0.84 | DRD2 (0.42) | DGAT1DRD2MMP2MMP9MMP8 | |
| SCHEMBL16234065 | 0.84 | CSNK2A1 (0.40) | GBA1 | |
| SCHEMBL21537936 | 0.83 | DGAT1 (0.45) | DGAT1MMP2MMP9MMP8MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220160887-A1 | PROGRAMMABLE POLYMERIC DRUGS | Sony Group Corporation (JP) | 2022-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220160887-A1 | PROGRAMMABLE POLYMERIC DRUGS | CHRM1, NCL, PBRM1 | DGAT1 4804/4885DRD2 1217/4885MMP2 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.